Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.2.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FK.1.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FK.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FT.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FT.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FT.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GJ.1.2.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GJ.1.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.25NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAGNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAGNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAGNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.9.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.9.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.9.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.4.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.4.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.4.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BK.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DJ.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used